Title of article :
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder
Author/Authors :
Rossom, Rebecca C. HealthPartners Institute, Minneapolis, MN USA , Sperl-Hillen, JoAnn M. HealthPartners Institute, Minneapolis, MN USA , O’Connor, Patrick J. HealthPartners Institute, Minneapolis, MN USA , Crain, A. Lauren HealthPartners Institute, Minneapolis, MN USA , Nightingale, Laurel HealthPartners Institute, Minneapolis, MN USA , Pylkas, Anne HealthPartners Medical Group, Minneapolis, MN USA , Huntley, Kristen V. Center for the Clinical Trials Network - National Institute on Drug Abuse, Bethesda, MA USA , Bart, Gavin University of Minnesota School of Medicine, Minneapolis, MN USA
Pages :
11
From page :
1
To page :
11
Abstract :
Objective Most Americans with opioid use disorder (OUD) do not receive indicated medical care. A clinical decision support (CDS) tool for primary care providers (PCPs) could address this treatment gap. Our primary objective was to build OUD-CDS tool and demonstrate its functionality and accuracy. Secondary objectives were to achieve high use and approval rates and improve PCP confidence in diagnosing and treating OUD. Methods A convenience sample of 55 PCPs participated. Buprenorphine-waivered PCPs (n = 8) were assigned to the intervention. Non-waivered PCPs (n = 47) were randomized to intervention (n = 24) or control (n = 23). Intervention PCPs received access to the OUD-CDS, which alerted them to patients at potentially increased risk for OUD or overdose and guided diagnosis and treatment. Control PCPs provided care as usual. Results The OUD-CDS was functional and accurate following extensive multi-phased testing. PCPs used the OUD-CDS in 5% of encounters with at-risk patients, far less than the goal of 60%. OUD screening confidence increased for all intervention PCPs and OUD diagnosis increased for non-waivered intervention PCPs. Most PCPs (65%) would recommend the OUD-CDS and found it helpful with screening for OUD and discussing and prescribing OUD medications. Discussion PCPs generally liked the OUD-CDS, but use rates were low, suggesting the need to modify CDS design, implementation strategies and integration with existing primary care workflows. Conclusion The OUD-CDS tool was functional and accurate, but PCP use rates were low. Despite low use, the OUD-CDS improved confidence in OUD screening, diagnosis and use of buprenorphine. NIH Trial registration NCT03559179. Date of registration: 06/18/2018. URL: https://clinicaltrials.gov/ct2/show/NCT03559179 Supplementary Information The online version contains supplementary material available at 10.1186/s13722-021-00245-7.
Farsi abstract :
فاقد چكيده فارسي
Keywords :
Opioid use disorder , Primary care , Clinical decision support
Journal title :
Addiction Science and Clinical Practice
Serial Year :
2021
Full Text URL :
Record number :
2623408
Link To Document :
بازگشت